John A Moyer

USPTO Granted Patents = 12 (Patent Applications = 1)

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 34(Granted Patents)

Location History:

West Chester, PA (US) (1985)
Bucks, PA (US) (1993)
New Hope, PA (US) (1990 - 2024)

Company Filing History:

8 out of 1,567

American Home Products Corporation

patents

2 out of 2,077

Janssen Pharmaceutica Nv

Years Active: 1985-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11974987 - Monoacylglycerol lipase modulators for use in autism spectrum disorders (2024-05-07),

2. 7897636 - Sulfamide derivative useful for the treatment of epilepsy (2011-03-01),

3. 7759346 - [[2-(amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain (2010-07-20),

4. 7098200 - [[2-(Amino-3,4-dioxo-1-cyclobuten-1-yl)amino]alkyl]-acid derivatives for the treatment of pain (2006-08-29),

5. 5530013 - Venlafaxine in the inducement of cognition enhancement (1996-06-25),

6. 5482940 - Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of (1996-01-09),

7. 5278160 - Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of (1994-01-11),

8. 5183819 - Use of fused bicyclic imides in the treatment of various CNS disorders (1993-02-02),

9. 5134141 - Antidepressant polycyclic imides to treat depression (1992-07-28),

10. 5106849 - Use of aryl- and heteroaryl piperazinyl carboxamides in the treatment of (1992-04-21),

11. 4920121 - Anxiolytic activity of N-(2-methoxyphenyl)piperazine (1990-04-24),

12. 4539407 - .beta.-Carboline anticonvulsants (1985-09-03),

Title: John A Moyer: Innovator in Pharmaceutical Research

Introduction

John A Moyer is a notable inventor based in New Hope, PA (US), recognized for his contributions to pharmaceutical research. He holds a total of 12 patents, showcasing his innovative spirit and dedication to advancing medical science.

Latest Patents

Among his latest patents, Moyer has developed monoacylglycerol lipase modulators for use in autism spectrum disorders. This invention relates to specific uses and methods involving 3.1.0 and 4.1.0 azabicycle compounds, which are aimed at treating autism spectrum disorder, including Asperger's syndrome. Additionally, he has created a sulfamide derivative useful for the treatment of epilepsy. This invention focuses on novel sulfamide derivatives and their pharmaceutical compositions, which can be administered either alone or in combination with other anticonvulsant and anti-epileptic agents.

Career Highlights

Throughout his career, Moyer has worked with prominent companies such as American Home Products Corporation and Janssen Pharmaceutica NV. His work in these organizations has significantly contributed to the development of innovative pharmaceutical solutions.

Collaborations

Moyer has collaborated with esteemed colleagues, including Magid A Abou-Gharbia and John P Yardley, further enhancing his research and development efforts in the pharmaceutical field.

Conclusion

John A Moyer's innovative contributions to pharmaceutical research, particularly in the treatment of autism spectrum disorders and epilepsy, highlight his role as a significant inventor in the industry. His work continues to impact the field positively.

This text is generated by artificial intelligence and may not be accurate.